JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

HDAC

A4095 Pracinostat (SB939)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: Pan-HDAC inhibitor

insoluble in H2O; ≥11.4 mg/mL
A4094 MC1568
3 Citation

Target: Histone Deacetylases (HDACs)

Summary: Class II HDAC inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥15.7 mg/mL
A4093 ITF2357 (Givinostat)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

≥23.8 mg/mL
A4092 CUDC-101
1 Citation

Target: Histone Deacetylases (HDACs)|EGFR|ErbB

Summary: Multitargeted HDAC inhibitor

≥21.7 mg/mL
A4091 PCI-34051
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC8 inhibitor,potent and selective

insoluble in H2O; insoluble in EtOH; ≥14.8 mg/mL
A4090 JNJ-26481585
3 Citation

Target: Histone Deacetylases (HDACs)

Summary: Potent HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.2 mg/mL
A4089 Mocetinostat (MGCD0103, MG0103)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,isotype-selective and potent

insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL
A4084 Vorinostat (SAHA, MK0683)
21 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
A4083 Rocilinostat (ACY-1215)
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: Selective HDAC6 inhibitor

≥21.675 mg/mL
A3860 Tasquinimod

Summary: Antiangiogenic and antineoplastic agent

insoluble in H2O; ≥20.32 mg/mL